Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2016 Feb 15;7:10660. doi: 10.1038/ncomms10660

A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells

Akshay K Ahuja 1, Karolina Jodkowska 2, Federico Teloni 3, Anna H Bizard 4, Ralph Zellweger 1, Raquel Herrador 1, Sagrario Ortega 5, Ian D Hickson 4, Matthias Altmeyer 3, Juan Mendez 2, Massimo Lopes 1,a
PMCID: PMC4756311  PMID: 26876348

Abstract

Embryonic stem cells (ESCs) represent a transient biological state, where pluripotency is coupled with fast proliferation. ESCs display a constitutively active DNA damage response (DDR), but its molecular determinants have remained elusive. Here we show in cultured ESCs and mouse embryos that H2AX phosphorylation is dependent on Ataxia telangiectasia and Rad3 related (ATR) and is associated with chromatin loading of the ssDNA-binding proteins RPA and RAD51. Single-molecule analysis of replication intermediates reveals massive ssDNA gap accumulation, reduced fork speed and frequent fork reversal. All these marks of replication stress do not impair the mitotic process and are rapidly lost at differentiation onset. Delaying the G1/S transition in ESCs allows formation of 53BP1 nuclear bodies and suppresses ssDNA accumulation, fork slowing and reversal in the following S-phase. Genetic inactivation of fork slowing and reversal leads to chromosomal breakage in unperturbed ESCs. We propose that rapid cell cycle progression makes ESCs dependent on effective replication-coupled mechanisms to protect genome integrity.

Inline graphicIn fast proliferating embryonic stem cells (ESC) the DNA damage response is activated by mechanisms that are as yet elusive. Here, Ahuja et al. link the DNA damage response to replication stress in mouse ESCs, caused by a short G1 phase, and propose fork remodelling as maintaining genome stability in embryos.

The earliest stages of mammalian embryogenesis are dedicated to the rapid division of totipotent cells in the morulas, later organized in the inner cell mass (ICM) of the blastocysts, from which embryonic stem cells (ESCs) are derived. Although ESCs can be maintained for long periods in cell culture, the equivalent cells in the ICM exist only transiently (5–6 cell divisions), in a period preceding the onset of differentiation1. Several reports have compared the DNA damage response (DDR) in ESCs with that in differentiated cells upon exogenous genotoxic insults2,3,4,5. However, little is known about how ESCs cope with endogenous stress that may arise during early embryogenesis. In ESCs, active proliferation needs to be compatible with accurate and complete DNA replication, to execute the developmental programme in a timely manner, without compromising genome stability in the embryo. Unexpectedly, it was previously reported that this stage is associated with constitutive DDR activation (phosphorylation of the histone variant H2AX, or γH2AX)6,7,8,9. However, as γH2AX appearance is not dependent on the activity of the apical checkpoint kinase ATM, and is not associated with the double-strand break (DSB) marker 53BP1, γH2AX was attributed to undefined peculiarities of ESC chromatin structure. Hence, the possible presence of DNA damage in these cells has remained controversial and elusive.

An important feature that sets ESCs apart from mature cells is the different organization of the cell cycle10,11. Differentiated cells spend a relatively large proportion of their time in the gap phases (G1 and G2) and lesser time in the S-phase. Conversely, asynchronously growing ESCs have remarkably short gap phases and spend most of their time in the S-phase, although the time spent for genome duplication is not significantly different from that in somatic cells12. In line with their high proliferative capacity, most positive cell cycle regulators and DNA replication factors (for example, CDC25A, CDC6, cyclins and so on) are extremely abundant in ESCs compared with mouse embryonic fibroblasts (MEFs)13 and their levels drastically drop down on ESC differentiation14. This unusual cell cycle control is orchestrated by key stem cell factors5,15 and was shown to be essential to maintain pluripotency in ESCs16,17. Furthermore, ESCs are reported to have a compromised G1–S checkpoint2,18. The tumour suppressor protein retinoblastoma, which is required for prevention of aberrant G1–S progression, thereby preventing damaged DNA from being replicated, is active in MEFs, but inactive in ESCs19. In principle, this could enable ESCs to enter S-phase in the presence of unrepaired damage.

In this study, we have investigated the molecular determinants of the constitutive DDR activation observed in ESCs. We found several unexpected markers of genotoxic stress during ESC replication, which explain activation of the Ataxia telangiectasia and Rad3 related (ATR) pathway and result from cell cycle adaptations of ESCs, specifically from the fast transition through the G1 phase. We propose that fast proliferating ESCs lack effective mechanisms to delay G2/M and G1/S transitions on incomplete replication, but effectively protect genome integrity by replication-coupled mechanisms. As hyperproliferation and replication problems in adult stem cells have been recently linked to cancer onset and stem cell attrition20,21, molecular mechanisms related to those described here in early embryogenesis may underlie key causative events in human disease.

Results

RPA/RAD51 chromatin loading in early embryogenesis

To shed light on the molecular determinants of γH2AX formation in ESCs, we tested whether other markers of genotoxic stress are also detectable in these cells. We confirmed that, unless irradiated, ESCs are devoid of 53BP1 foci (Supplementary Fig. 1a)9, but also found that γH2AX in unperturbed ESCs is invariably associated with extensive chromatin loading of RPA32 and RAD51, two single-stranded DNA (ssDNA)-binding proteins involved in recombinational mechanisms at DSBs and stalled forks22. All three markers are lost simultaneously on induction of differentiation by removal of leukaemia inhibition factor (LIF)23, as soon as the stem cell marker Oct4 is lost from the differentiating cells (ESC-d) and while cells are still largely undergoing active proliferation (Fig. 1a–c). Similar observations were made in different ES cell lines, under different cell culture conditions (Supplementary Fig. 1b,c) and were confirmed in vivo by staining of pre-implantation mouse embryos at the morula and blastocyst stage (Fig. 1d; Supplementary Figs 2 and 3). Biochemical fractionation confirmed extensive chromatin loading of RPA and RAD51 in ESCs, compared with the levels observed in differentiating and differentiated cells (Fig. 1e). Furthermore, ATM inhibition by KU55933 reduced infrared-induced γH2AX in ESCs, but had no effect on endogenous γH2AX levels in these cells (Fig. 1f; Supplementary Fig. 1d,e), as previously reported6. Conversely, 8-h treatment with ATR inhibitors (ETP-46464 or VE-821) did not affect ESC proliferation, but markedly reduced endogenous γH2AX (Fig. 1f; Supplementary Fig. 1f–h). Altogether, these data strongly suggest that ESCs experience bona fide replication stress, which is rapidly suppressed on onset of differentiation.

Figure 1. Replication stress markers are present in vitro in ESCs and in vivo in ICM cells.

Figure 1

Open in a new tab

(a) Immunofluorescence (IF) staining of an embryonic stem cell (ESC) colony and partially differentiated ESCs (ESC-d; 3d from LIF removal) for the stem cell marker Oct4, the DNA damage marker γH2AX and chromatin-bound ssDNA-binding proteins RPA32 and RAD51. Scale bars, 25 μm. (b) FACS analysis of EdU incorporation and DNA content (DAPI) in ESC and ESC-d. The percentage of cells in the different cell cycle phases is indicated. (c) Quantification of double IF-stainings displayed in a) in ESC and ESC-d. A minimum of 150 cells were scored in each double staining. (d) IF staining for γH2AX, RPA32 and RAD51 of E3.5 blastocysts. Number of embryos analysed per staining was 12, 11 and 9, respectively. Representative images are shown (see also Supplementary Figs 2 and 3). Scale bar, 25 μm. (e) Immunoblot detection of the indicated proteins after biochemical fractionation performed on ESC, ESC-d and mouse embryonic fibroblasts (MEFs). Cytosolic kinase MEK2 and chromatin-bound H3 serve as fractionation controls. Original films were scanned at high resolution and the intensity of immunoblot signals was quantified with ImageJ. C, chromatin-enriched fraction; S, soluble fraction (includes cytosol and abundant nucleosoluble proteins); W, whole-cell extract. Histograms represent chromatin/soluble (C/S) ratios for RPA32 (left) and RAD51 (right). (f) FACS-based quantification of γH2AX staining in ESCs on mock, ATM inhibitor (ATMi) or ATR inhibitor (ATRi) treatment. All these experiments were performed in duplicate. a.u., arbitrary units.

ssDNA and fork remodelling in ESCs until differentiation onset

As RPA32/RAD51 staining are suggestive of ssDNA accumulation, we applied an established single-molecule approach to stabilize replication intermediates in cultured cells and visualize them by electron microscopy24. Replication intermediates in ESCs display a striking accumulation of ssDNA gaps, with multiple gaps present in over 60% of the forks (Fig. 2a,b), frequently also on parental DNA (Fig. 2a; Supplementary Fig. 4a). As for other experimental conditions associated with template discontinuities25,26, ssDNA gap accumulation is accompanied by frequent replication fork reversal (Fig. 2c,d; Supplementary Fig. 4b), a protective transaction previously described at replication forks challenged by cancer chemotherapeutic treatments26,27,28. Strikingly, both ssDNA accumulation and fork reversal are rapidly and markedly suppressed on induction of differentiation (Fig. 2b,d). Incomplete Oct4 loss at this early time point of differentiation is likely to account for the residual levels of ssDNA and reversed forks observed (Fig. 2b,d; Supplementary Fig. 4c). These marks of replication stress in ESCs are associated with a marked reduction in replication fork speed measured by DNA fibre spreading compared with differentiating and differentiated counterparts (Fig. 2e). Reduced fork speed in ESCs was also observed with shorter labelling times and on inhibition of origin firing (Supplementary Fig. 4d–f), excluding that these data reflect frequent fork termination due to reduced replicon size in these cells29.

Figure 2. ESCs display massive accumulation of ssDNA gaps, reduced fork speed and frequent fork reversal.

Figure 2

Open in a new tab

(a,c) Electron micrographs of representative replication forks from ESCs, with indicated parental (P) and daughter (D) duplexes. White arrows indicate ssDNA gaps; black arrow points to the regressed arm (R) of a reversed fork. Insets: (a), a magnified ssDNA gap; (c), the four-way junction at the reversed fork. Scale bar, 500 bp (=217 nm), 200 bp in inset. (b) Frequency of replication forks isolated from ESCs and differentiating ESCs (ESC-d) with the indicated number of ssDNA gaps. (d) Frequency of reversed replication forks isolated from ESC and ESC-d. The number of replication intermediates analysed is indicated in parentheses. Similar results were obtained in an independent experiment. (e) DNA fibre spreading of ESC, ESC-d and MEF. CldU/IdU-containing tracts were immunostained in red and green, respectively. Two representative fibres are shown for ESCs and ‘Differ. ESCs'. The IdU replicated track length was computed using Mann–Whitney test.

Replication stress in ESCs does not perturb mitosis

While addressing the molecular determinants of ssDNA accumulation in ESCs, we tested several hypotheses, possibly associated with peculiarities of stem cell biology, using FACS/IF-based assessment of γH2AX on genetic or chemical perturbations (Supplementary Figs 5 and 6). In this way, we excluded that the DDR in ESCs specifically reflects oxidative stress or nucleotide shortage (Supplementary Fig. 5a–f), previously reported to mediate replication stress in other experimental systems30,31,32. Furthermore, two different transcription inhibitors failed to reduce γH2AX levels in ESCs (Supplementary Fig. 5g–j); thus, although replication/transcription interference may contribute to replication stress in ESCs, it does not seem the key underlying mechanism of constitutive DDR activation in early embryogenesis. We also excluded that ssDNA gap accumulation results from active demethylation—a base excision repair-associated process mediating the epigenetic reprogramming in ESCs33—as inactivation of key enzymatic activities in this process also had no detectable effect on the observed γH2AX levels (Supplementary Fig. 6a–e). Although partial and combined contributions of the above mechanisms cannot be formally ruled out, we next focused on other potential ESC-specific sources of genotoxic stress. As both ssDNA accumulation and fork reversal were recently reported on induction of multiple replication rounds within a given S-phase25, we hypothesized that replication stress in unperturbed ESCs may reflect their peculiar cell cycle progression10 with replication rounds in rapid succession—spaced by short gap phases12—and the absence of a functional G1/S checkpoint2,18. To test the hypothesis that specific cell cycle constraints may underlie the observed marks of replication stress, we delayed progression through G2/M- or G1/S-phase transitions and tested whether those cells experiencing a prolonged G1 or G2 phase would detectably suppress the DDR (γH2AX−), while retaining stem cell properties (Oct4+). G2/M arrest was achieved by a PLK1 (BI-6727) or a CDK1 inhibitor (RO-3306), while G1 delay was induced by a CDK4/6 (LY-2835219) or a CDC7 inhibitor (PHA-767491). Only a small fraction of cycling ESCs displayed low levels of γH2AX while quickly transitioning through G1 (Fig. 3a–c). The proportion of γH2AX− Oct4+ cells was not increased by extending the length of the G2 phase (Fig. 3a–c). In contrast, a delay in the G1/S transition did result in the accumulation of γH2AX− Oct4+ cells, particularly evident in the cells effectively arrested with unreplicated DNA on CDC7 inhibition (Fig. 3a–c). These data, combined with previous observations (Figs 1 and 2), suggest that accumulated replication stress in ESCs is unlikely to be addressed in mitosis, but can instead be dealt within the following G1, if cells are allowed to spend sufficient time in this phase. We thus tested directly whether cycling ESCs display aberrant mitotic structures that are typically associated with unfinished replication in somatic cells, such as chromatin bridges, micronuclei and ultrafine DNA bridges34. Surprisingly, despite markedly lower levels of replication stress marks than in ESCs (Figs 1 and 2), MEFs displayed higher endogenous levels of unresolved mitotic structures, which as expected were further induced by aphidicolin addition, an established treatment to challenge replication completion (Fig. 3d–f). Conversely, albeit displaying and signalling marked features of replication stress, unperturbed ESCs showed limited numbers of mitotic defects, which were only marginally increased on aphidicolin treatments (Fig. 3d–f). These surprising data strongly suggest that the mitotic process in ESCs is tuned to tolerate elevated levels of replication stress, as those reported above for cultured ESCs and mouse blastocysts.

Figure 3. Delaying the G1/S and not the G2/M transition suppresses H2AX phosphorylation in ESCs.

Figure 3

Open in a new tab

(a) FACS analysis of Oct4 and γH2AX in ESCs on the indicated treatments. PLK1i (BI-6727) and CDK1i (RO-3306) treatments delay progression through G2/M, while CDK4/6i (LY-2835219) and CDC7i (PHA-767491) treatments delay S-phase entry. The top-left quadrant identifies the subpopulation of stem cells (Oct4+) that display negative γH2AX staining. (b) Student's t-test of the subpopulation of Oct4+ γH2AX− cells (red) identified in a, across three independent experiments. Error bars indicate s.d. **P<0.005, ***P<0.0005. (c) Cell cycle distribution, assessed by FACS-based DNA content (DAPI), of the samples in a. The total population is displayed in grey and the subpopulation of Oct4+ γH2AX− in red. Where present, Oct4+ γH2AX− cells are invariably detected in G1. (d–f) Representative images and graphical distribution of untreated (UNT) and aphidicolin (APH)-treated MEFs and ESCs displaying different mitotic defects (d, chromatin bridges; e, micronuclei; f, ultrafine bridges). Scale bars, 10 μm. The histograms indicate mean and standard deviations from three independent experiments.

A short G1 causes replication stress in stem and mature cells

Differently from the G2/M-phase, prolongation of the G1 phase by two different inhibitors significantly reduced γH2AX signalling in ESCs (Fig. 3a–c). Intriguingly, the G1 phase was recently reported to allow the assembly of large 53BP1 foci (nuclear bodies, NBs) in somatic cells35. These specialized chromatin machineries in the G1 phase are clearly distinct from small DNA damage-induced 53BP1 foci and were suggested to shield residual DNA damage or unreplicated regions from the previous S-phase, possibly assisting their repair before or during a new replication round35. We thus tested whether a prolonged G1 phase on ESC differentiation could be linked to the presence of 53BP1 NBs in this cell cycle phase. To achieve this, we combined quantitative image-based cytometry36—which identifies G1 cells in asynchronous cell populations by low DNA content (DAPI) and lack of EdU incorporation (Supplementary Fig. 6f)—with quantitative measurements of focal protein accumulation37,38. This approach indeed revealed that, in unperturbed conditions, ESCs in G1 are practically devoid of 53BP1 NBs. However, shortly after induction of differentiation (ESC-d), along with prolongation of this cell cycle stage, G1 cells accumulated 53BP1 NBs (Fig. 4a,b; Supplementary Fig. 6f). To further explore the hypothesis that a short G1 phase underlies constitutive DDR activation in ESCs, we performed the reciprocal experiment, shortening the G1 phase in differentiated cells (MEFs) and assessing markers of replication stress and DDR activation. Shortening of the G1 phase in differentiated mouse cells can be achieved by inactivation of the APC/C activator FZR1 (ref. 39). Indeed, small interfering RNA (siRNA)-mediated FZR1 depletion in MEFs reduced the fraction of G1 cells and concomitantly decreased the number of 53BP1 NBs per G1 nucleus (Fig. 4c–e), thus phenocopying what we found in unperturbed ESCs with an intrinsically short G1 phase. Importantly, in these experimental conditions, S-phase cells displayed markedly increased γH2AX signalling, reduced replication fork progression by DNA fibre assays and higher levels of ssDNA gaps and reversed forks detected by our electron microscopy approach (Fig. 4e–h). Altogether, these results strongly suggest that a prolonged G1 phase and/or the associated assembly of 53BP1 NBs are required to avoid replication stress and to prevent the consequent activation of the ATR-checkpoint in the following S-phase.

Figure 4. A shortened G1 phase impairs 53BP1 nuclear body formation and causes replication stress in the following S-phase.

Figure 4

Open in a new tab

(a) Representative IF images of ESC and ESC-d stained with EdU and 53BP1. ESC differentiation detectably increase 53BP1 nuclear signals in EdU-negative cells. Scale bar, 25 μm. (b) Microscopically discernible 53BP1 nuclear bodies (NBs) in G1 nuclei (as identified by low DAPI and low EdU signals) were quantified in asynchronous populations of ESC and ESC-d by software-assisted segmentation and feature extraction (Supplementary Fig. 6f). Comparable results were observed in two additional, independent experiments. (c) Western blot analysis of FZR1 levels in mock-depleted (siLuc) and FZR1-depleted (siFZR1) MEFs, 96 h after siRNA transfection. TFIIH is used as loading control. (d) Microscopically discernible 53BP1 NBs specifically in G1 nuclei of asynchronous populations of mock- and FZR1-depleted MEFs were quantified as in b. (b,d) **P<0.005, ***P<0.0005 (Mann–Whitney test) (e) FACS analysis for DNA synthesis (EdU incorporation), DNA content (DAPI) and DDR activation (γH2AX) in mock-depleted and FZR1-depleted MEFs. Plots depict EdU incorporation versus DAPI in both populations. γH2AX positive cells are depicted in red. Cell populations in G1 and S-phase are also depicted. (f) DNA fibre analysis to assess fork progression in mock-depleted and FZR1-depleted MEFs. The IdU replicated track length was computed using Mann–Whitney test. (g,h) EM-based assessment of the percentage of replication intermediates containing ssDNA gaps (g) and the percentage of reversed forks (h) in genomic DNA extracted from mock-depleted and FZR1-depleted MEFs.

A prolonged G1 phase suppresses replication stress in ESCs

Prompted by the above evidence, we tested directly whether a transient G1 arrest in ESCs—by CDC7 inhibition (Fig. 3a)—would be sufficient to suppress the marks of replication stress in the following S-phase. On release from this transient G1 arrest, ESCs indeed displayed reduced γH2AX staining and a faster rate of replication fork progression (Fig. 5a,b). Strikingly, this transient delay in the G1/S transition was also sufficient to effectively suppress ssDNA accumulation and fork reversal on ESC replication intermediates in vivo analysed by electron microscopy (Fig. 5c,d). Taken together, these data strongly suggest that all unusual molecular hallmarks of ESC replication reflect the rapid succession of multiple replication rounds.

Figure 5. A prolonged G1 phase in ESCs suppresses replication stress in the following S-phase.

Figure 5

Open in a new tab

(a) FACS analysis of EdU incorporation and DNA content (DAPI) in control ESCs, ESCs treated with CDC7i, and ESCs on release from a transient CDC7i arrest (PHA-767491, 10 μM, 8 h). The gated (red) subpopulation of cells in early S-phase was analysed quantitatively for γH2AX staining (a.u., arbitrary units). (b) IdU replicated track length, computed using Mann–Whitney test, in control ESCs and cells released from a transient CDC7i arrest. (c) Frequency of replication forks isolated from control ESCs and on release from a transient CDC7i arrest, displaying the indicated number of ssDNA gaps. (d) Frequency of reversed replication forks isolated from control ESCs and on release from a transient CDC7i arrest.

Fork slowing and reversal protect ESCs from chromosome breaks

We and others have recently reported some genetic dependencies for replication fork slowing and reversal on genotoxic treatments of somatic cells, that is, Poly (ADP-ribose) polymerase (PARP) and the central recombinase RAD51 (refs 26, 28, 40). Therefore, we set out to test the physiological relevance of replication fork remodelling in the face of endogenous replication stress in otherwise unperturbed ESCs. Indeed, PARP inhibition by Olaparib in ESCs led to unrestrained fork progression (Fig. 6a) and to a marked (threefold) reduction in the frequency of reversed forks (Fig. 6b). Importantly, these defects were associated with detectable accumulation of small chromosomal fragments—likely resulting from frequent replication fork breakage (Fig. 6c)—and with defective completion of genome duplication (Supplementary Fig. 7a). Due to the abundance and the essential role of RAD51 in ESCs, its complete depletion by siRNA was difficult to achieve (Supplementary Fig. 7b). However, the observed reduction in RAD51 levels was sufficient to significantly increase fork speed and progressively impair efficient fork reversal (Fig. 6d,e), in keeping with recent evidence in somatic cells on genotoxic treatments28. Also in this independent condition of defective fork slowing and reversal, we observed significant and progressive accumulation of chromosomal breakage. The breaks occur while most cells are still actively proliferating (Supplementary Fig. 7c) and thus precede cell cycle arrest, which is expected on prolonged RAD51 depletion41. Taken together, these data suggest that replication fork slowing and reversal are essential in unperturbed ESCs to prevent the breakage of replicating chromosomes, which are challenged by endogenous replication stress.

Figure 6. PARP and Rad51 are essential for replication fork protection in ESCs.

Figure 6

Open in a new tab

(a,d) DNA fibre analysis of mock-treated ESCs, ESCs treated with Olaparib (a), mock-transfected ESCs and ESCs transfected with siRad51 for 48 and 72 h (d). The graphs show the statistical analysis of IdU replicated track length. (b,e) Frequency of reversed replication forks isolated from mock-treated ESCs and ESCs treated with Olaparib (b), mock-transfected ESCs and ESCs transfected with siRad51 for 48 and 72 h (e). (c,f) Pulse field gel electrophoresis (PFGE) to assess accumulation of DNA double-strand breaks (DSBs) in mock-treated ESCs, ESCs treated with Olaparib (c), mock-transfected ESCs and ESCs transfected with siRad51 for 48 and 72 h (f). DSBs equal to and above 500 Mb compact into a single band and DSBs smaller than 500 Mb can be detected as a smear as indicated alongside the gel. DSB (band plus smear) intensity from three independent experiments was quantified and plotted.

Discussion

The process of genomic duplication is usually challenged by under-replicated regions, which are frequently associated with late-replicating and difficult-to-replicate loci34,42. Thus, full genome replication often requires the delay of mitotic onset; furthermore, cells may eventually attempt segregation of partially replicated chromosomes, completing DNA synthesis in the following cell cycle34. Proliferating somatic cells take advantage of a prolonged G1 phase to complete genome duplication, using specialized mechanisms—such as the assembly of 53BP1 NBs35—that are proposed to mediate template quality control before the onset of a new replication round (Fig. 7). In line with this notion, we now report that shortening the G1 phase in differentiated cells is sufficient to impair the assembly of 53BP1 NBs and to induce the full set of unusual replication features detected in unperturbed ESCs. Conversely, prolongation of the G1 phase is sufficient to restore 53BP1 NBs assembly and to largely suppress replication stress marks in ESCs (Supplementary Fig. 7d). Thus, our data bring further support to the notion that 53BP1 NBs do represent specialized chromatin factories promoting DNA repair before or during a new replication round35, in response to both endogenous and exogenous sources of genotoxic stress (Supplementary Fig. 7d). The detailed molecular mechanisms underlying these DNA repair events will merit further investigation.

Figure 7. Model depicting differential control of genome stability in ESCs and proliferating somatic cells.

Figure 7

Open in a new tab

Under-replicated regions and residual DNA damage are unavoidably present at the end of each S-phase in both ESCs and somatic cells. However, owing to the brief gap phases, ESCs channel a high number of these lesions in the following S-phase and protect genome integrity by extensive fork reversal and replication-coupled repair. Conversely, differentiated cells have prolonged gap phases, assemble 53BP1 NBs and repair most of these lesions before S-phase entry (see also Supplementary Fig. 7d).

In contrary to differentiated cells, ESCs appear highly tolerant of endogenous and exogenous replication stress while undergoing mitosis. We found reduced levels of unresolved mitotic structures, despite obvious markers of endogenous replication stress being detected in these cells, even when exogenous stress was induced by aphidicolin treatment. It is likely that the type of DNA damage accumulated in these cells at the end of replication—mostly ssDNA gaps on replicated duplexes—may not interfere with spindle elongation and chromosome segregation and may thus be ineffective in activating cell cycle checkpoints. Whether specific molecular features of the mitotic apparatus actively promote cell division in ESCs even in the presence of residual stress will need further investigation. Besides this unrestrained transition through mitosis, a particularly short G1 phase is also somehow instrumental in ESCs maintaining self-renewal16,17. Furthermore, these cells lack the molecular mechanisms that delay S-phase entry in the presence of DNA damage18. In light of these combined observations, we propose that ESCs do not finalize a replication round before the onset of the following S-phase (Fig. 7). This leads to a discontinuous replication template and forces these cells to undergo simultaneous replication and repair synthesis. The abundance of simultaneous DNA synthesis events in these cells, exacerbated by the increased usage of replication origins43, may exhaust limiting factors for DNA synthesis and further affect the replication process44, contributing to the observed accumulation of ssDNA. In this respect, prolonging the G1 phase may assist the following replication round not only by providing more time for full genome duplication, but also by modulating the level of limiting replication factors and/or the number and distribution of licensed replication origins, thereby preventing accumulation of replication stress. In keeping with this, treating ESCs with Roscovitine—a CDK inhibitor known to limit origin activity—leads to a fivefold increase in the number of stem cells losing γH2AX, mostly residing within the G1 phase (Supplementary Fig. 7e,f).

Despite the short residence time in G1 phase and the associated consequences in terms of replication stress, we propose that ESCs can effectively tolerate this stress for those few cell division cycles that they undergo in nature, by exploiting replication-coupled control of genome stability. Unperturbed ESCs seem extremely efficient in promoting replication fork reversal, even in the absence of exogenous damage. In line with recent data obtained in somatic cells on genotoxic treatments26,28, we report here that the accumulation of reversed forks in ESCs depends on the key recombinase RAD51 and on PARP activity. Genetic inactivation of either factor in unperturbed ESCs impairs effective fork slowing and reversal, which rapidly results in chromosomal breakage. These results strongly suggest that controlled fork progression and remodelling play a pivotal role in protecting the integrity of replicating chromosomes in ESCs, which have extremely short gap phases and thus rely entirely on genome maintenance during replication (Fig. 7). Considering the abundance of RAD51 and its essential function in early embryogenesis41,45, it is tempting to speculate that the essential developmental role of RAD51 and possibly other homologous recombination factors reflects their extensive involvement in replication fork remodelling, to prevent chromosomal breakage during active proliferation in early embryogenesis. Conversely, the well-established role of HR factors in DSB repair may become more relevant in germ and somatic cells after programmed DSB formation and/or exposure to environmental clastogens. In this respect, as new molecular mechanisms modulating in vivo replication fork remodelling and restart are being uncovered27, it will be important to test their specific contribution to genome integrity in early embryogenesis. Interestingly, besides the G1 shortening induced in MEFs by FZR1 depletion, also the activation of oncogenes that accelerate the G1–S transition—that is, CyclinE46—induces in somatic cells molecular hallmarks of replication stress that are almost identical to those described here in ESCs, including frequent fork reversal. Somatic cells can tolerate CyclinE-induced replication stress for several cell cycles before inducing chromosomal breakage47. In this respect, our data in ESCs consolidate the emerging notion that fork reversal represents a widely used strategy for genome maintenance, in the face of different types of replication stress27. It is important to note that—besides the DNA damage tolerance mechanisms described here—genome maintenance in early embryogenesis is further supported by elimination of damaged cells by apoptosis, reportedly a very active process in this biological context18.

It will be crucial, albeit challenging, to extend these studies to adult stem cells (for example, hematopoietic stem cells), particularly in experimental conditions where they are actively induced to proliferate by specific stimuli48. This is particularly important in light of recent reports suggesting that replication stress contributes to aging and attrition of hematopoietic stem cells, upon physiological stimuli to proliferate21,49. Remarkably, the proliferative properties of different populations of adult stem cells have also been recently linked to the propensity of different tissues to undergo tumorigenesis, suggesting that replication problems in adult stem cells can be initiating events in cancer20. In light of these important findings, the working model described here for replication stress in early embryogenesis may prime new mechanistic studies on different populations of adult stem cells, especially under cancer-relevant experimental conditions. Similar mechanisms may also be relevant in the derivation of induced pluripotent stem cells, and may contribute to explaining the reported signs of replication stress and genome damage, which limit induced pluripotent stem cell derivation and raise concerns for their therapeutic applications50,51,52,53.

Methods

Cells and cell culture

E14, Stat3 and JM8 mouse ES cell lines, derived from the ICM of mouse blastocysts, were provided by Paolo Cinelli (Clinic for Trauma Surgery, University of Zurich), while immortalized MEFs were provided by F. Althaus (Institute of Pharmacology and Toxicology, University of Zurich). E14 were cultivated in ‘ESC medium'+LIF and differentiation was started by LIF removal. Stat3 and JM8 were cultivated in ‘N2B27 medium' (see composition below) +2i and differentiation was started by 2i removal. ESC medium: Dulbecco's Modified Eagle Medium (Sigma), 15% FBS (Gibco), 1 mM Sodium Pyruvate (Sigma), 1 × Non-Essential Amino Acids (Sigma), 1 × Penicillin-Streptomycin-L-Glutamine (Life Technologies), 0.1 mM β-Mercaptoethanol (Sigma). N2B27 medium: 1:1 Neurobasal Medium:Dulbecco's Modified Eagle Medium/F-12 (Life Technologies), 1 × Penicillin-Streptomycin-L-Glutamine (Life Technologies), 1 × N2-Supplement (Life Technologies), 1 × B27 Supplement (Life Technologies), 0.05 mM 2-Mercaptoethanol (Life Technologies). LIF: 1,000 U ml−1 (Millipore). 2i: 1 μM PD0325901 (Stemgent), 3 μM CHIR99021 (Stemgent). ESCs were cultivated on feeder cells (MEFs inactivated with 10 mg ml−1 mitomycin C) for at least two passages before performing experiments. ESCs were then separated from feeder cells by trypsinization and centrifugation, and grown on gelatinized tissue culture dishes (0.1% Gelatin from porcine skin, Sigma).

Mouse morula and blastocyst isolation and staining

Mice used in these experiments were hosted at the CNIO animal facility and maintained in SPF conditions. All procedures were approved by the Ethics Committee of the Instituto de Salud Carlos III and the competent organism of the Comunidad Autonoma de Madrid. 6- to 8-week-old B6/CBA or CD1 females were induced to superovulate by intraperitoneal injection of 5 IU pregnant mare serum gonadotropin (PMSG) followed 48 h later by 5 IU of human chorionic gonadotropin (HCG). Matings with fertile males of the same genetic background were set up from the day of human chorionic gonadotropin administration. Morulas were collected at day E2.5 and blastocysts at day E3.5 of embryonic development. In all cases, embryos were collected in M2 medium (Sigma). After removal of the zona pellucida with acid Tyrode's solution (Sigma), embryos were fixed with 4% paraformaldehyde, permabilized with 0.25% Triton X-100 in PBS, blocked and incubated with primary antibodies diluted in blocking solution (0.1% BSA, 0.01% Tween 20, 2% normal donkey serum) overnight at 4 °C, washed and incubated in secondary antibodies for 1 h at room temperature. Stained embryos were placed in a drop of blocking solution containing 4 μg ml−1 DAPI on a glass-bottom dish, covered with mineral oil and kept at 4 °C until confocal microscopy analysis in a Leica TCS SP5 microscope equipped with objective HCX PL APO CS 63 × Water (NA 1.2). Z stacks were taken with a 1–2 μm step size. Images were processed using ImageJ.

The following primary antibodies were used: γH2AX (Millipore, 05–636) 1:500; RPA2, Cell Signalling, 2208S) 1:100; RAD51 (Santa Cruz Biotechnology, sc-8349) 1:250. Secondary antibodies: Alexa Fluor 555 Donkey anti-Mouse (Life Technologies, A31570); Alexa Fluor 594 Donkey anti-Rat (Life Technologies, A21209); Alexa Fluor 488 Donkey anti-Rabbit (Life Technologies, A21206) 1:500.

Epifluorescence and confocal microscopy

For immunofluorescence, cultured ES cells were fixed with 4% formaldehyde/PBS, permeabilized with 0.25% Triton X-100 and stained for γ-H2AX (1:500), Oct4 (1:500), RPA (1:100), Rad51 (1:250), 53BP1 (1:500) and EdU as indicated, detected by appropriate secondary antibodies (Alexa Fluor, 1:500) or Click-IT reaction (Life Technologies), and mounted with Vectashield (Vector Laboratories). 0.1% PBST (0.1% Tween in 1 × PBS) was used for washes after primary and secondary antibody incubations. Images were acquired at × 63 on a Leica DMRB microscope or on a Leica TCS SP5 confocal microscope,

For quantitative image analyses (Fig. 4b,d and Supplementary Fig. 6f), automated wide-field microscopy was performed on a Leica DMI 6000 inverted microscope equipped with a motorized stage, a Tri-band bandpass filter (DAPI/FITC/TX; BP387/11/BP 494/20/BP 575/20) and a 12-bit monochrome EMCCD camera (Leica DFC 350 FX, 1,392 × 1,040 pixels, 6.4 μm pixel size). All images were acquired under non-saturating conditions with a HCX PLAN APO × 40 (NA 1.25–0.75) oil objective. Unbiased, automated image acquisition was performed with the Leica Matrix Screening Software. All images were imported to the Olympus ScanR Image Analysis Software Version 2.5.1, a dynamic background correction was applied, and nuclei segmentation was performed using the integrated EdgeDetection module. Focal accumulations of 53BP1 and γH2AX were quantified by using the integrated SpotDetector module. Colour-coded scatter plots of asynchronous cell populations were generated with Spotfire data visualization software (TIBCO). P values (Fig. 4b,d) were calculated by Mann–Whitney test.

Transfections and treatments

For knockdown experiments, cells were transfected 24–96 h before sample collection with the indicated siRNA using RNAiMax transfection reagent (Life Technologies) according to the manufacturer's instructions: siLUC (100–200 nM; 5′-GGUACGCGGAAUACUUCGAdTdT-3′), siFZR1, siRad51, siAPE1, siTDG (100–200 nM siGENOME SMARTpool Dharmacon). The following reagents were used to treat ES cells for the indicated time at the indicated final concentrations before collection: ATM inhibitor (KU55933, Kudos; 8 h, 10 μM); ATR inhibitor (ETP-46464, provided by O. Fernandez-Capetillo, CNIO, Madrid; 8 h, 5 μM; VE-821, Selleckchem; 8 h, 10 μM); PARP inhibitor (Olaparib, Selleckchem; 24 h, 10 μM); Reducing/scavenging agent: (N-acetylcysteine, Sigma; 10 h, 10 mM); Transcription inhibitors (Cordycepin, Sigma; 100 min, 50 μM; Alpha-amanitin, kindly provided by P. Janscak, 3–6 h, 20 μM); Ape1 inhibitor (Methoxyamine hydrochloride, Sigma; 10 h, 1 μM); CDK4/6 inhibitor (LY2835219, Selleckchem; 4 h, 1 μM); Cdc7 inhibitors (PHA-767491, Sigma; 8 h, 10 μM; XL-413, kindly provided by C. Santocanale, 4 h, 10 μM); CDK1 inhibitor (RO-3306, Sigma; 10 h, 10 μM); PLK inhibitor (BI-6727, Selleckchem; 4 h, 500 nM); Nucleosides (EmbryoMax, Millipore; 24 h, 5 ×). Roscovitine (Seliciclib, Selleckchem; 8 h, 20 μM).

Flow cytometry

For flow cytometric analysis for γ-H2AX/EdU/DAPI, cells were labelled for 30 min with 10 μM EdU, harvested and fixed for 15 min with 4% formaldehyde/PBS. Cells were washed with 1% BSA/PBS, pH 7.4, permeabilized with 0.5% saponin/1% BSA/PBS and stained with anti-γ-H2AX antibody (#05–636; EMD Millipore) for 2 h, followed by incubation with a suitable secondary antibody for 30 min. Incorporated EdU was labelled according to the manufacturer's instructions (#C-10425; Life Technologies). For flow cytometric analysis for γ-H2AX/Oct4/DAPI, cells were fixed and permeabilized as described above, followed by incubation with antibodies against γ-H2AX (#9718; Cell Signalling Technology) and Oct4 (#611203, BD Transduction Laboratories) and suitable secondary antibodies. In both assays, DNA was stained with 1 μg ml−1 DAPI. Samples were measured on a Cyan ADP flow cytometer (Beckman Coulter) and analysed with Summit software v4.3 (Beckman Coulter). For statistical analyses, Mann–Whitney test was applied to compute if differences in signal intensities were significant using Prism (GraphPad Software).

Western blotting

Cells were collected and either snap frozen in liquid nitrogen or immediately lysed using 2 × Laemmli buffer. Protein amounts were normalized using known concentrations of BSA and protein absorbance was measured using Cary 60 Spectrophotometer technology. SDS-gels were run at 15–18 mA and proteins were either wet-blotted overnight (30 V, 4 °C) or for 2 h (100 V, 4 °C) on Hybond ECL transfer membrane (GE Healthcare). Membranes were blocked in 2% ECL Advance Blocking Reagent (GE Healthcare) in 0.1% TBST (1 × TBS supplemented with 0.1% Tween 20) for at least 30 min and incubated with primary antibodies overnight at 4 °C or at room temperature for 4 h in blocking solution and secondary antibodies were added for 1 h at room temperature (in blocking solution). Membranes were washed three times with 0.1% TBST, 10' each, after primary and secondary antibody incubations and detected with ECL detection reagent (GE healthcare). Differences in protein levels were normalized against the loading control and the signal intensity was quantified using ImageJ. For complete, uncropped blots with size markers, see Supplementary Fig. 8.

Pulse field gel electrophoresis

ES cells were transfected or treated as indicated and cells were harvested by trypsinization. Agarose plugs of 2.5 × 105 cells were prepared in a disposable plug mold (Bio-Rad Laboratories). Plugs were then incubated in lysis buffer (100 mM EDTA, 1% (wt/vol) sodium lauroyl sarcosinate, 0.2% (wt/vol) sodium deoxycholate, and 1 mg ml−1 proteinase K) at 37 °C for 72 h. Plugs were then washed four times in 20 mM Tris-HCl, pH 8.0 and 50 mM EDTA before loading onto an agarose gel. Electrophoresis was performed for 21 h at 14 °C in 0.9% (wt/vol) Pulse Field Certified Agarose (Bio-Rad Laboratories) containing Tris-borate/EDTA buffer in a pulse field gel electrophoresis (PFGE) apparatus (CHEF DR III; Bio-Rad Laboratories), according to the following protocol (block I: 9 h, 120° included angle, 5.5 V cm−1, 30–18 s switch; block II: 6 h, 117° included angle, 4.5 V cm−1, 18–9-s switch; block III: 6 h, 112° included angle, 4.0 V cm−1, 9–5 s switch). The gel was then stained with ethidium bromide and analysed by the AlphaImager system (ProteinSimple). Relative DNA DSB) levels were assessed by comparing DSB signals for each treatment to the background levels observed in untreated conditions using ImageJ.

Antibodies

The following primary antibodies were used: γ-H2AX (#05–636; EMD Millipore), 53BP1 (ab21083; Abcam), Oct3/4 ((#611203; BD Transduction Laboratories), RPA (NA19L; Calbiochem), Rad51 (sc-8349; Santa Cruz Biotechnology, Inc.), GAPDH (#AB2302; Millipore), Fzr1 (ab3242; Abcam), RNA pol II (provided by Pavel Janscak), Ape1 (NB100–116; Novus), Tdg (provided by P. Schär), hTOPO3α (IE3; a kind gift from Aventis Pharma). For chromatin fractionation, Rad51(sc-8349; Santa Cruz Biotechnology, Inc.), RPA32 (2208S; Cell Signaling), MEK2 (610235; BD Transduction Laboratories), Histone-H3 (ab1791; Abcam). The secondary antibodies used were Alexa Fluor conjugates (Alexa Fluor 488, 594 and 647; Life Technologies) for flow cytometry and immunofluorescence and anti-rabbit and anti-mouse ECL (GE Healthcare) for western blotting.

DNA fibre analysis

Cells were sequentially pulse-labelled with 30 μM CldU and 250 μM IdU for 20 min (15 min where indicated) each and harvested. Cells were then lysed and DNA fibres stretched onto glass slides by tilting them. The fibres were then denatured with 2.5 M HCl for 1 h, washed with PBS and blocked with 0.2% Tween 20 in 1% BSA/PBS. CldU and IdU tracks were detected with anti-BrdU antibodies recognizing CldU (ab6326; Abcam) and IdU (347580; BD), respectively, and appropriate secondary antibodies. Images were acquired with a microscope (model DMRB; Leica) equipped with a camera (model DFC360 FX; Leica). Images were taken at × 63 using Leica Application Suite 3.3.0. CldU and IdU tract lengths were measured using ImageJ. For statistical analyses, Mann–Whitney test was applied to compute if differences in tract lengths were significant using Prism (GraphPad Software).

Electron microscopy analysis of DNA replication intermediates in mouse cells

In vivo psoralen cross-linking, isolation of total genomic DNA and enrichment of the replication intermediates and their electron microscopy visualization were performed as described22. In brief, cells were harvested, and genomic DNA was cross-linked by two rounds of incubation in 10 μM 4,5′,8-trimethylpsoralen, followed by 3 min of irradiation with 366 nm ultraviolet light. Cells were lysed, and genomic DNA was isolated from the nuclei by proteinase K digestion and phenol–chloroform extraction. Purified DNA was digested QJ;with PvuII-HF and replication intermediates were enriched on a BND cellulose column. Electron microscopy samples were prepared by spreading the DNA on carbon-coated grids and visualized by platinum rotary shadowing. Images were acquired on a transmission electron microscope (G2 Spirit; FEI Tecnai) and analysed with ImageJ (National Institutes of Health).

Chromatin fractionation

ESCs, differentiating ESCs and MEFs were subjected to biochemical fractionation according to a standard protocol54. The distribution of proteins between equivalent amounts of the soluble and chromatin-enriched fractions was analysed by immunoblot.

Analysis of mitotic defects

Cells were inoculated on poly-L-Lysine coated glass slides (SIGMA-Aldrich) and grown for 16 h in the absence or in the presence of 0.3 μM Aphidicolin. For ‘micronuclei' cells were additionally treated for 6 h with 5 μg ml−1 Cytochalasin-B before fixation. For ‘chromatin bridges' and ‘micronuclei', cells were fixed with 4% paraformaldehyde for 20 min and permeabilized with 0.5% Triton X-100 in PBS for 1 h. For ‘ultrafine bridges', cells were fixed using 4% paraformaldehyde, 0.5% Triton X-100 in PBS for 20 min. Slides were saturated using BSA 3%, Triton X-100 0.5% in PBS for a minimum of 2 h. Slides were then mounted in Vectashield mounting medium containing DAPI. The number of chromatin bridge-containing Anaphase/Telophase cells, micronuclei-containing bi-nucleated cells or UFB-containing Anaphase/Telophase cells was scored manually.

Additional information

How to cite this article: Ahuja, A. K. et al. A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells. Nat. Commun. 7:10660 doi: 10.1038/ncomms10660 (2016).

Supplementary Material

Supplementary Information

Supplementary Figures 1-8

ncomms10660-s1.pdf (10.7MB, pdf)

Acknowledgments

We thank the Center for Microscopy and Image Analysis of the University of Zurich and the Confocal Microscopy Unit and Transgenic Animal Unit (Biotechnology Programme, CNIO) for technical assistance. We are grateful to P. Cinelli and his group members for technical assistance in the initial phases of this project, and C. Santocanale, P. Schär, P. Janscak and A. Sartori for sharing reagents. We also thank S. Ferrari, P. Cinelli, L. Sommer, M. Manz and all current and past members of the Lopes group for useful discussions. This work was supported by the Swiss National Science Foundation grants 31003A_146924 and PDFMP3_127523 to M.L. and grant PP00P3_150690/1 to M.A., by SAF2013–44866R (to S.O.) and BFU2013–49153-P grants from Spanish Ministry of Economy and Competitiveness (MINECO) to J.M., and by the European Research Council, Nordea Foundation and Danish National Research Foundation to I.D.H.

Footnotes

Author contributions Unless specified below, A.K.A. performed all experiments with cultured ESCs, with occasional help of R.H. K.J. and S.O. performed blastocyst isolation and staining. K.J. performed the biochemical fractionation assays. F.T. and M.A. designed and analysed quantitative imaging experiments. A.H.B. performed the mitotic analyses. R.Z. performed the electron microscopy analysis on MEFs. M.L. designed and supervised the project and wrote the manuscript, A.K.A, J.M., M.A. and I.D.H revised the manuscript.

References

  1. Lanner F. Lineage specification in the early mouse embryo. Exp. Cell. Res. 321, 32–39 (2014). [DOI] [PubMed] [Google Scholar]
  2. Aladjem M. I. et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8, 145–155 (1998). [DOI] [PubMed] [Google Scholar]
  3. Hong Y. & Stambrook P. J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl Acad. Sci. USA 101, 14443–14448 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Tichy E. D. & Stambrook P. J. DNA repair in murine embryonic stem cells and differentiated cells. Exp. Cell. Res. 314, 1929–1936 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. van der Laan S., Tsanov N., Crozet C. & Maiorano D. High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. Mol. Cell. 52, 366–379 (2013). [DOI] [PubMed] [Google Scholar]
  6. Banath J. P. et al. Explanation for excessive DNA single-strand breaks and endogenous repair foci in pluripotent mouse embryonic stem cells. Exp. Cell. Res. 315, 1505–1520 (2009). [DOI] [PubMed] [Google Scholar]
  7. Chuykin I. A., Lianguzova M. S., Pospelova T. V. & Pospelov V. A. Activation of DNA damage response signalling in mouse embryonic stem cells. Cell Cycle 7, 2922–2928 (2008). [DOI] [PubMed] [Google Scholar]
  8. Turinetto V. et al. High basal gammaH2AX levels sustain self-renewal of mouse embryonic and induced pluripotent stem cells. Stem Cells 30, 1414–1423 (2012). [DOI] [PubMed] [Google Scholar]
  9. Ziegler-Birling C., Helmrich A., Tora L. & Torres-Padilla M. E. Distribution of p53 binding protein 1 (53BP1) and phosphorylated H2A.X during mouse preimplantation development in the absence of DNA damage. Int. J. Dev. Biol. 53, 1003–1011 (2009). [DOI] [PubMed] [Google Scholar]
  10. Ballabeni A. et al. Cell cycle adaptations of embryonic stem cells. Proc. Natl Acad. Sci. USA 108, 19252–19257 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. White J. et al. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell 16, 2018–2027 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Li V. C., Ballabeni A. & Kirschner M. W. Gap 1 phase length and mouse embryonic stem cell self-renewal. Proc. Natl Acad. Sci. USA 109, 12550–12555 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tichy E. D. et al. The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels. Stem Cell Res. 9, 124–134 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fujii-Yamamoto H., Kim J. M., Arai K. & Masai H. Cell cycle and developmental regulations of replication factors in mouse embryonic stem cells. J. Biol. Chem. 280, 12976–12987 (2005). [DOI] [PubMed] [Google Scholar]
  15. Zhang X. et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J. Cell Biol. 184, 67–82 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Becker K. A. et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 209, 883–893 (2006). [DOI] [PubMed] [Google Scholar]
  17. Li V. C. & Kirschner M. W. Molecular ties between the cell cycle and differentiation in embryonic stem cells. Proc. Natl Acad. Sci. USA 111, 9503–9508 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stambrook P. J. & Tichy E. D. Preservation of genomic integrity in mouse embryonic stem cells. Adv. Exp. Med. Biol. 695, 59–75 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Savatier P., Huang S., Szekely L., Wiman K. G. & Samarut J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809–818 (1994). [PubMed] [Google Scholar]
  20. Tomasetti C. & Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78–81 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walter D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549–552 (2015). [DOI] [PubMed] [Google Scholar]
  22. Carr A. M. & Lambert S. Replication stress-induced genome instability: the dark side of replication maintenance by homologous recombination. J. Mol. Biol. 425, 4733–4744 (2013). [DOI] [PubMed] [Google Scholar]
  23. Posfai E., Tam O. H. & Rossant J. Mechanisms of pluripotency in vivo and in vitro. Curr. Top. Dev. Biol. 107, 1–37 (2014). [DOI] [PubMed] [Google Scholar]
  24. Neelsen K. J., Chaudhuri A. R., Follonier C., Herrador R. & Lopes M. Visualization and interpretation of eukaryotic DNA replication intermediates in vivo by electron microscopy. Methods Mol. Biol. 1094, 177–208 (2014). [DOI] [PubMed] [Google Scholar]
  25. Neelsen K. J. et al. Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template. Genes Dev. 27, 2537–2542 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ray Chaudhuri A. et al. Topoisomerase I poisoning results in PARP-mediated replication fork reversal. Nat. Struct. Mol. Biol. 19, 417–423 (2012). [DOI] [PubMed] [Google Scholar]
  27. Neelsen K. J. & Lopes M. Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat. Rev. Mol. Cell. Biol. 16, 207–220 (2015). [DOI] [PubMed] [Google Scholar]
  28. Zellweger R. et al. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J. Cell Biol. 208, 563–579 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hiratani I. et al. Global reorganization of replication domains during embryonic stem cell differentiation. PLoS Biol. 6, e245 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Bermejo R., Lai M. S. & Foiani M. Preventing replication stress to maintain genome stability: resolving conflicts between replication and transcription. Mol. Cell 45, 710–718 (2012). [DOI] [PubMed] [Google Scholar]
  31. Berquist B. R. & Wilson D. M. 3rd Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett. 327, 61–72 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Bester A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435–446 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kohli R. M. & Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472–479 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mankouri H. W., Huttner D. & Hickson I. D. How unfinished business from S-phase affects mitosis and beyond. EMBO J. 32, 2661–2671 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lukas C. et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat. Cell Biol. 13, 243–253 (2011). [DOI] [PubMed] [Google Scholar]
  36. Toledo L. I. et al. A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat. Struct. Mol. Biol. 18, 721–727 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Altmeyer M. et al. The chromatin scaffold protein SAFB1 renders chromatin permissive for DNA damage signaling. Mol. Cell 52, 206–220 (2013). [DOI] [PubMed] [Google Scholar]
  38. Gudjonsson T. et al. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150, 697–709 (2012). [DOI] [PubMed] [Google Scholar]
  39. Sigl R. et al. Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosis. J. Cell Sci. 122, 4208–4217 (2009). [DOI] [PubMed] [Google Scholar]
  40. Sugimura K., Takebayashi S., Taguchi H., Takeda S. & Okumura K. PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA. J. Cell Biol. 183, 1203–1212 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yoon S. W., Kim D. K., Kim K. P. & Park K. S. Rad51 regulates cell cycle progression by preserving G2/M transition in mouse embryonic stem cells. Stem Cells Dev. 23, 2700–2711 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Letessier A. et al. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470, 120–123 (2011). [DOI] [PubMed] [Google Scholar]
  43. Ryba T. et al. Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. Genome Res. 20, 761–770 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yoshida K. et al. The histone deacetylases sir2 and rpd3 act on ribosomal DNA to control the replication program in budding yeast. Mol. Cell 54, 691–697 (2014). [DOI] [PubMed] [Google Scholar]
  45. Tsuzuki T. et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl Acad. Sci. USA 93, 6236–6240 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ekholm-Reed S. et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165, 789–800 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Neelsen K. J., Zanini I. M., Herrador R. & Lopes M. Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J. Cell Biol. 200, 699–708 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wilson A., Laurenti E. & Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Curr. Opin. Genet. Dev. 19, 461–468 (2009). [DOI] [PubMed] [Google Scholar]
  49. Flach J. et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512, 198–202 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Momcilovic O. et al. DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS ONE 5, e13410 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Pasi C. E. et al. Genomic instability in induced stem cells. Cell Death Differ. 18, 745–753 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Pera M. F. Stem cells: The dark side of induced pluripotency. Nature 471, 46–47 (2011). [DOI] [PubMed] [Google Scholar]
  53. Ruiz S. et al. Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells. Nat. Commun. 6, 8036 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mendez J. & Stillman B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20, 8602–8612 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information

Supplementary Figures 1-8

ncomms10660-s1.pdf (10.7MB, pdf)

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES